{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T09:08:08Z","timestamp":1776244088019,"version":"3.50.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004761","name":"Natural Science Foundation of Hainan Province","doi-asserted-by":"publisher","award":["grant number 824QN372"],"award-info":[{"award-number":["grant number 824QN372"]}],"id":[{"id":"10.13039\/501100004761","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Cultivation project of Hainan General Hospital","award":["grant number 2021QNXM18"],"award-info":[{"award-number":["grant number 2021QNXM18"]}]},{"name":"the Hainan Province Clinical Medical Center"},{"name":"National Natural Science Foundation of China Regional Project","award":["grant number 82260339"],"award-info":[{"award-number":["grant number 82260339"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med Imaging"],"DOI":"10.1186\/s12880-025-01917-5","type":"journal-article","created":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T09:46:54Z","timestamp":1758880014000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Dynamic contrast-enhanced magnetic resonance imaging-based radiomics for predicting programmed death ligand 1 expression in nasopharyngeal carcinoma"],"prefix":"10.1186","volume":"25","author":[{"given":"Wen-zhu","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia-li","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meng-ying","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-ting","family":"Liao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi-jie","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-yuan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,9,26]]},"reference":[{"key":"1917_CR1","doi-asserted-by":"publisher","first-page":"e49968","DOI":"10.2196\/49968","volume":"9","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Rumgay H, Li M, et al. Nasopharyngeal cancer incidence and mortality in 185 countries in 2020 and the projected burden in 2040: Population-Based global epidemiological profiling. JMIR Public Health Surveill. 2023;9:e49968.","journal-title":"JMIR Public Health Surveill"},{"key":"1917_CR2","doi-asserted-by":"publisher","first-page":"110143","DOI":"10.1016\/j.radonc.2024.110143","volume":"193","author":"JCH Chow","year":"2024","unstructured":"Chow JCH, Lee J, Lai MMP, et al. Multi-domain neurocognitive impairment following definitive intensity-modulated radiotherapy for nasopharyngeal cancer: a cross-sectional study. Radiother Oncol. 2024;193:110143.","journal-title":"Radiother Oncol"},{"key":"1917_CR3","doi-asserted-by":"publisher","first-page":"224","DOI":"10.6004\/jnccn.2022.0016","volume":"20","author":"JJ Caudell","year":"2022","unstructured":"Caudell JJ, Gillison ML, Maghami E, et al. NCCN Guidelines(R) insights: head and neck cancers, version 1.2022. J Natl Compr Canc Netw. 2022;20:224\u201334.","journal-title":"J Natl Compr Canc Netw"},{"key":"1917_CR4","doi-asserted-by":"publisher","first-page":"e18130","DOI":"10.1016\/j.heliyon.2023.e18130","volume":"9","author":"H Wang","year":"2023","unstructured":"Wang H, Luo K, Zhan Y, et al. Role of beta-catenin in PD-L1 expression of nasopharyngeal carcinoma. Heliyon. 2023;9:e18130.","journal-title":"Heliyon"},{"key":"1917_CR5","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1002\/pro6.1219","volume":"8","author":"Z Zhang","year":"2024","unstructured":"Zhang Z, Chen X, Yuan T. Precision radiotherapy for nasopharyngeal carcinoma. Precis Radiat Oncol. 2024;8:37\u201341.","journal-title":"Precis Radiat Oncol"},{"key":"1917_CR6","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1001\/jamaoncol.2019.5367","volume":"6","author":"J Duan","year":"2020","unstructured":"Duan J, Cui L, Zhao X, et al. Use of immunotherapy with programmed cell death 1 vs programmed cell death ligand 1 inhibitors in patients with cancer: A systematic review and Meta-analysis. JAMA Oncol. 2020;6:375\u201384.","journal-title":"JAMA Oncol"},{"key":"1917_CR7","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1038\/s41591-021-01444-0","volume":"27","author":"HQ Mai","year":"2021","unstructured":"Mai HQ, Chen QY, Chen D, et al. Toripalimab or placebo plus chemotherapy as first-line treatment in advanced nasopharyngeal carcinoma: a multicenter randomized phase 3 trial. Nat Med. 2021;27:1536\u201343.","journal-title":"Nat Med"},{"key":"1917_CR8","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1007\/s00259-019-04654-4","volume":"47","author":"L Zhao","year":"2020","unstructured":"Zhao L, Zhuang Y, Fu K, et al. Usefulness of [(18)F]fluorodeoxyglucose PET\/CT for evaluating the PD-L1 status in nasopharyngeal carcinoma. Eur J Nucl Med Mol Imaging. 2020;47:1065\u201374.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1917_CR9","doi-asserted-by":"publisher","first-page":"3044","DOI":"10.1111\/cas.15433","volume":"113","author":"J Yang","year":"2022","unstructured":"Yang J, Chen J, Liang H, et al. Nasopharyngeal cancer cell-derived Exosomal PD-L1 inhibits CD8\u2009+\u2009T-cell activity and promotes immune escape. Cancer Sci. 2022;113:3044\u201354.","journal-title":"Cancer Sci"},{"key":"1917_CR10","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1093\/clinchem\/hvaa170","volume":"66","author":"B Hu","year":"2020","unstructured":"Hu B, Sun M, Wang Z, et al. Prognostic value of programmed cell Death-Ligand 1 expression in Tumor-Infiltrating lymphocytes and viral load in peripheral blood mononuclear cells for Epstein-Barr Virus-Positive nasopharyngeal carcinoma. Clin Chem. 2020;66:1219\u201327.","journal-title":"Clin Chem"},{"key":"1917_CR11","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1093\/jnci\/djx055","volume":"109","author":"V Verma","year":"2017","unstructured":"Verma V, Simone CB 2nd, Krishnan S, et al. The rise of radiomics and implications for oncologic management. J Natl Cancer Inst. 2017;109:10.","journal-title":"J Natl Cancer Inst"},{"key":"1917_CR12","doi-asserted-by":"publisher","first-page":"3401","DOI":"10.1007\/s00259-022-05783-z","volume":"49","author":"L Monaco","year":"2022","unstructured":"Monaco L, De Bernardi E, Bono F, et al. The digital biopsy in non-small cell lung cancer (NSCLC): a pilot study to predict the PD-L1 status from radiomics features of [18F]FDG PET\/CT. Eur J Nucl Med Mol Imaging. 2022;49:3401\u201311.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1917_CR13","doi-asserted-by":"publisher","first-page":"5362","DOI":"10.1007\/s00330-022-08651-4","volume":"32","author":"YM Zheng","year":"2022","unstructured":"Zheng YM, Yuan MG, Zhou RQ, et al. A computed tomography-based radiomics signature for predicting expression of programmed death ligand 1 in head and neck squamous cell carcinoma. Eur Radiol. 2022;32:5362\u201370.","journal-title":"Eur Radiol"},{"key":"1917_CR14","doi-asserted-by":"publisher","first-page":"3759","DOI":"10.1007\/s00330-020-06675-2","volume":"30","author":"SJ Hectors","year":"2020","unstructured":"Hectors SJ, Lewis S, Besa C, et al. MRI radiomics features predict immuno-oncological characteristics of hepatocellular carcinoma. Eur Radiol. 2020;30:3759\u201369.","journal-title":"Eur Radiol"},{"key":"1917_CR15","doi-asserted-by":"publisher","first-page":"5392","DOI":"10.1007\/s00330-020-06847-0","volume":"30","author":"KJ Park","year":"2020","unstructured":"Park KJ, Lee JL, Yoon SK, et al. Radiomics-based prediction model for outcomes of PD-1\/PD-L1 immunotherapy in metastatic urothelial carcinoma. Eur Radiol. 2020;30:5392\u2013403.","journal-title":"Eur Radiol"},{"key":"1917_CR16","doi-asserted-by":"publisher","first-page":"e23166","DOI":"10.1016\/j.heliyon.2023.e23166","volume":"9","author":"Q Li","year":"2023","unstructured":"Li Q, Huang Y, Xia Y, et al. Radiogenomics for predicting microsatellite instability status and PD-L1 expression with machine learning in endometrial cancers: A multicenter study. Heliyon. 2023;9:e23166.","journal-title":"Heliyon"},{"key":"1917_CR17","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1007\/s00261-022-03709-9","volume":"48","author":"X Gu","year":"2023","unstructured":"Gu X, Yu X, Shi G, et al. Can PD-L1 expression be predicted by contrast-enhanced CT in patients with gastric adenocarcinoma? A preliminary retrospective study. Abdom Radiol (NY). 2023;48:220\u20138.","journal-title":"Abdom Radiol (NY)"},{"key":"1917_CR18","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.3390\/cancers12071979","volume":"12","author":"JV Gaustad","year":"2020","unstructured":"Gaustad JV, Hauge A, Wegner CS, et al. DCE-MRI of tumor hypoxia and hypoxia-Associated aggressiveness. Cancers (Basel). 2020;12:1979.","journal-title":"Cancers (Basel)"},{"key":"1917_CR19","doi-asserted-by":"publisher","first-page":"6273","DOI":"10.3390\/cancers13246273","volume":"13","author":"R Lo Gullo","year":"2021","unstructured":"Lo Gullo R, Wen H, Reiner JS, et al. Assessing PD-L1 expression status using radiomic features from Contrast-Enhanced breast MRI in breast cancer patients: initial results. Cancers (Basel). 2021;13:6273.","journal-title":"Cancers (Basel)"},{"key":"1917_CR20","doi-asserted-by":"publisher","first-page":"778","DOI":"10.3892\/ol.2021.13039","volume":"22","author":"N Tekiki","year":"2021","unstructured":"Tekiki N, Fujita M, Okui T, et al. Dynamic contrast-enhanced MRI as a predictor of programmed death ligand-1 expression in patients with oral squamous cell carcinoma. Oncol Lett. 2021;22:778.","journal-title":"Oncol Lett"},{"key":"1917_CR21","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.radonc.2021.09.016","volume":"164","author":"W Huang","year":"2021","unstructured":"Huang W, Zhang Q, Wu G, et al. DCE-MRI quantitative transport mapping for noninvasively detecting hypoxia inducible factor-1alpha, epidermal growth factor receptor overexpression, and Ki-67 in nasopharyngeal carcinoma patients. Radiother Oncol. 2021;164:146\u201354.","journal-title":"Radiother Oncol"},{"key":"1917_CR22","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1002\/jmri.29109","volume":"60","author":"Z Wu","year":"2024","unstructured":"Wu Z, Lin Q, Wang H, et al. Intratumoral and peritumoral radiomics based on preoperative MRI for evaluation of programmed cell death Ligand-1 expression in breast cancer. J Magn Reson Imaging. 2024;60:588\u201399.","journal-title":"J Magn Reson Imaging"},{"key":"1917_CR23","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1002\/(SICI)1522-2586(199909)10:3<223::AID-JMRI2>3.0.CO;2-S","volume":"10","author":"PS Tofts","year":"1999","unstructured":"Tofts PS, Brix G, Buckley DL, et al. Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and symbols. J Magn Reson Imaging. 1999;10:223\u201332.","journal-title":"J Magn Reson Imaging"},{"key":"1917_CR24","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1007\/s00330-012-2740-7","volume":"23","author":"B Huang","year":"2013","unstructured":"Huang B, Wong CS, Whitcher B, et al. Dynamic contrast-enhanced magnetic resonance imaging for characterising nasopharyngeal carcinoma: comparison of semiquantitative and quantitative parameters and correlation with tumour stage. Eur Radiol. 2013;23:1495\u2013502.","journal-title":"Eur Radiol"},{"key":"1917_CR25","doi-asserted-by":"publisher","first-page":"955866","DOI":"10.3389\/fonc.2022.955866","volume":"12","author":"WZ Li","year":"2022","unstructured":"Li WZ, Wu G, Li TS, et al. Dynamic contrast-enhanced magnetic resonance imaging-based radiomics for the prediction of progression-free survival in advanced nasopharyngeal carcinoma. Front Oncol. 2022;12:955866.","journal-title":"Front Oncol"},{"key":"1917_CR26","doi-asserted-by":"crossref","unstructured":"Chan SC, Ng SH, Yeh CH et al. Prognostic utility of (18)F-FDG PET\/MRI with intravoxel incoherent motion imaging in nasopharyngeal carcinoma. Eur J Nucl Med Mol Imaging 2025.","DOI":"10.1007\/s00259-025-07425-6"},{"key":"1917_CR27","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1007\/s00432-021-03764-7","volume":"148","author":"G Wu","year":"2022","unstructured":"Wu G, Huang W, Xu J, et al. Dynamic contrast-enhanced MRI predicts PTEN protein expression which can function as a prognostic measure of progression-free survival in NPC patients. J Cancer Res Clin Oncol. 2022;148:1771\u201380.","journal-title":"J Cancer Res Clin Oncol"},{"key":"1917_CR28","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.mri.2020.07.005","volume":"72","author":"HJ Meyer","year":"2020","unstructured":"Meyer HJ, Hohn AK, Surov A. Associations between histogram analysis parameters derived from dynamic-contrast enhanced MRI and PD L1-expression in head and neck squamous cell carcinomas. A preliminary study. Magn Reson Imaging. 2020;72:117\u201321.","journal-title":"Magn Reson Imaging"},{"key":"1917_CR29","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1007\/s13244-012-0196-6","volume":"3","author":"F Davnall","year":"2012","unstructured":"Davnall F, Yip CS, Ljungqvist G, et al. Assessment of tumor heterogeneity: an emerging imaging tool for clinical practice? Insights Imaging. 2012;3:573\u201389.","journal-title":"Insights Imaging"},{"key":"1917_CR30","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s13550-023-00956-9","volume":"13","author":"X Zhao","year":"2023","unstructured":"Zhao X, Zhao Y, Zhang J, et al. Predicting PD-L1 expression status in patients with non-small cell lung cancer using [(18)F]FDG PET\/CT radiomics. EJNMMI Res. 2023;13:4.","journal-title":"EJNMMI Res"},{"key":"1917_CR31","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s42492-023-00149-0","volume":"6","author":"H Li","year":"2023","unstructured":"Li H, Huang W, Wang S, et al. Comprehensive integrated analysis of MR and DCE-MR radiomics models for prognostic prediction in nasopharyngeal carcinoma. Vis Comput Ind Biomed Art. 2023;6:23.","journal-title":"Vis Comput Ind Biomed Art"},{"key":"1917_CR32","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1186\/s12885-024-12209-6","volume":"24","author":"X Cao","year":"2024","unstructured":"Cao X, Wang X, Song J, et al. Pretreatment multiparametric MRI radiomics-integrated clinical hematological biomarkers can predict early rapid metastasis in patients with nasopharyngeal carcinoma. BMC Cancer. 2024;24:435.","journal-title":"BMC Cancer"},{"key":"1917_CR33","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1007\/s00330-023-09987-1","volume":"34","author":"Y Lin","year":"2024","unstructured":"Lin Y, Yang Z, Chen J, et al. A contrast-enhanced CT radiomics-based model to identify candidates for deintensified chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma patients. Eur Radiol. 2024;34:1302\u201313.","journal-title":"Eur Radiol"},{"key":"1917_CR34","doi-asserted-by":"publisher","first-page":"2781","DOI":"10.1038\/s41467-023-38407-7","volume":"14","author":"DW Lim","year":"2023","unstructured":"Lim DW, Kao HF, Suteja L, et al. Clinical efficacy and biomarker analysis of dual PD-1\/CTLA-4 Blockade in recurrent\/metastatic EBV-associated nasopharyngeal carcinoma. Nat Commun. 2023;14:2781.","journal-title":"Nat Commun"},{"key":"1917_CR35","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s40644-023-00587-2","volume":"23","author":"X Zhong","year":"2023","unstructured":"Zhong X, Li L, Yin J, et al. Reproducibility and usefulness of quantitative apparent diffusion coefficient measurements for predicting program death-ligand 1 expression in nasopharyngeal carcinoma. Cancer Imaging. 2023;23:98.","journal-title":"Cancer Imaging"}],"container-title":["BMC Medical Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-025-01917-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12880-025-01917-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12880-025-01917-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T09:46:57Z","timestamp":1758880017000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedimaging.biomedcentral.com\/articles\/10.1186\/s12880-025-01917-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,26]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1917"],"URL":"https:\/\/doi.org\/10.1186\/s12880-025-01917-5","relation":{},"ISSN":["1471-2342"],"issn-type":[{"value":"1471-2342","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,26]]},"assertion":[{"value":"13 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol was approved by the Ethics Review Board of the Hainan Affiliated Hospital of Hainan Medical University in accordance with the Declaration of Helsinki, and the requirement for informed consent was waived.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All authors read and approved the final manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"377"}}